Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study

BACKGROUND: Circulating immune cells influence the efficacy of cancer therapy. This study aimed to investigate the prognostic values of different peripheral blood leukocyte (PBL) biomarkers in non-small lung cancer (NSCLC) patients treated with chemoradiotherapy. METHODS: An independent cohort of 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Min, Xu, Qinghua, Yang, Shuangyan, Han, Shuiyun, Zhu, Yaoyao, Lin, Qingren, Sun, Xiaojiang, Liu, Hui, Xu, Yaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661896/
https://www.ncbi.nlm.nih.gov/pubmed/33209890
http://dx.doi.org/10.21037/atm-20-6484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661896/
https://www.ncbi.nlm.nih.gov/pubmed/33209890
http://dx.doi.org/10.21037/atm-20-6484

Ejemplares similares